BRIACELL THERAPEUTICS CORP. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BRIACELL THERAPEUTICS CORP. stock issued during period, value, new issues for the quarter ending 2026-04-30 was $0.00, a 100.00% decline year-over-year.
- BRIACELL THERAPEUTICS CORP. stock issued during period, value, new issues for the quarter ending 2026-01-31 was $27.87M, a 494.48% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. stock issued during period, value, new issues for the quarter ending 2025-07-31 was $13.56M.
- BRIACELL THERAPEUTICS CORP. stock issued during period, value, new issues for the quarter ending 2025-04-30 was $14.71M.
- BRIACELL THERAPEUTICS CORP. stock issued during period, value, new issues for fiscal 2025 was $44.63M, a 909.91% increase from fiscal 2024.
- BRIACELL THERAPEUTICS CORP. stock issued during period, value, new issues for fiscal 2024 was $4.42M, a 10.47% increase from fiscal 2023.
- BRIACELL THERAPEUTICS CORP. stock issued during period, value, new issues for fiscal 2023 was $4.00M.
- BRIACELL THERAPEUTICS CORP. stock issued during period, value, new issues for fiscal 2021 was $12.36M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-09 | |
| 2026-01-31 | $27.87M 10-Q · filed 2026-03-10 | |
| 2025-07-31 | $13.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-16 | $44.63M 10-K · filed 2025-10-16 |
| 2025-04-30 | $14.71M 10-Q · filed 2026-06-09 | |
| 2025-01-31 | $4.69M 10-Q · filed 2026-03-10 | |
| 2024-10-31 | $11.67M 10-Q · filed 2025-12-11 | |
| 2024-07-31 | $4.42M 10-K · filed 2025-10-16 | |
| 2023-07-31 | $4.00M 10-K · filed 2024-10-29 | |
| 2021-07-31 | $12.36M 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |